(即时多来源)英语人工智能快讯/Englishi AI news

广告

欢迎来到科技前沿 | TSFrontier,探索科技的最前沿! YouTube 科技前沿 | TSFrontier 频道

翻译:



AWS and Bluesight build AI for hospital 340B compliance

AWS (Amazon Web Services) has explained how Bluesight developed Prism, an AI layer that connects hospital pharmacy and compliance data across its product suite. Prism Assistant for ControlCheck has reached general availability and operates across 20 health systems, according to AWS vendor statements. Meanwhile, a multi-product agent for 340B Group Purchasing Organisation (GPO) compliance remains […]

The post AWS and Bluesight build AI for hospital 340B compliance appeared first on AI News.

Read more

AI agent crawlers now need permission. Here’s how to get it

AI agent crawlers, the bots that fetch pages in real time on behalf of a person waiting for an answer, will be blocked by default on a slice of the web from September 15 onwards. Cloudflare announced the change on July 1, and most of the coverage since then has focused on Google. The more useful part […]

The post AI agent crawlers now need permission. Here’s how to get it appeared first on AI News.

Read more

How to shrink the token budget without shrinking the team

Jensen Huang has a test for whether an engineer is worth keeping, and it comes with a token budget attached. Speaking on the All-In Podcast at the close of GTC 2026, the Nvidia chief executive said that if a $500,000 engineer’s annual AI token consumption came in under half their salary, “I am going to […]

The post How to shrink the token budget without shrinking the team appeared first on AI News.

Read more

AWS GraphRAG deployment cuts drug research cycles by 87%

A recent AWS GraphRAG deployment reduced drug research and development cycles in pharmaceutical environments by 87 percent. This acceleration is achieved by integrating previously separated proprietary databases into a unified and queryable knowledge graph. Historically, initial data gathering and screening phases took over six months per iteration, yielding a low five percent success rate. Crucial […]

The post AWS GraphRAG deployment cuts drug research cycles by 87% appeared first on AI News.

Read more

NHS AI blood test could reduce invasive womb cancer checks

Several NHS hospitals are preparing to use an AI-powered blood test to help assess women referred for possible womb cancer before invasive checks are carried out. According to The Guardian, around 90,000 postmenopausal women in England are referred by GPs each year for checks after experiencing heavy bleeding. About 10,000 women are diagnosed with womb […]

The post NHS AI blood test could reduce invasive womb cancer checks appeared first on AI News.

Read more



Insilico Medicine advances AI drug for IPF to Phase III trials

Insilico Medicine is advancing to Phase III human trials for testing a drug identified by AI targeting idiopathic pulmonary fibrosis (IPF). This progression supplies the computational drug discovery sector with empirical test cases, advancing an AI medicine past early safety evaluations into late-stage efficacy validation. IPF destroys respiratory capacity through severe lung tissue scarring. Patients […]

The post Insilico Medicine advances AI drug for IPF to Phase III trials appeared first on AI News.

Read more

L’Oreal, Mondelez, and Nestle use AI to speed product development

L’Oreal is using AI to shorten product development timelines and identify new uses for ingredients already present in its portfolio. The French cosmetics group has applied AI in its laboratories for the past four years, with Fabrice Megarbane, president of L’Oreal’s consumer products division, telling Reuters that the technology helps the company predict how molecules […]

The post L’Oreal, Mondelez, and Nestle use AI to speed product development appeared first on AI News.

Read more

China’s AI companion rules: what Beijing is really going after

An AI companion sounds dystopian, but it has become a common thread in the wider conversation about the perils of generative AI. What it refers to is essentially a conversational agent built to sustain an ongoing, personal relationship with a user, with the memory and steady persona that keep it consistent from one session to […]

The post China’s AI companion rules: what Beijing is really going after appeared first on AI News.

Read more

Takeda signs $600M AI drug discovery deal with Insilico

Takeda has entered a strategic collaboration with Hong Kong-based Insilico Medicine to use AI in early-stage drug discovery across the Japanese pharmaceutical company’s therapeutic areas. The companies did not disclose which therapeutic areas or disease targets will be covered under the collaboration. The agreement gives Takeda access to Insilico’s Pharma.AI platform, which supports biological target […]

The post Takeda signs $600M AI drug discovery deal with Insilico appeared first on AI News.

Read more

NVIDIA BioNeMo accelerates Anthropic Claude Science

Anthropic Claude Science now integrates the NVIDIA BioNeMo Agent Toolkit to accelerate computational life sciences research. Anthropic has launched the public beta of Claude Science, an AI workbench built for scientific research. The platform enables scientists to converse directly with digital agents using natural language to execute end-to-end research workflows. This system connects natively to […]

The post NVIDIA BioNeMo accelerates Anthropic Claude Science appeared first on AI News.

Read more



Deploying retail AI to scale personalisation and customer insight

Optimising retail AI infrastructure drives the successful deployment of personalisation systems and real-time customer insight. Leaders are replacing static customer interaction patterns with data pipelines capable of modifying the user environment during a live session. Static layouts and broad segmentation rules fail to satisfy modern conversion targets. Deployments demonstrate that traditional demographic categorisation generates insufficient […]

The post Deploying retail AI to scale personalisation and customer insight appeared first on AI News.

Read more

Japan’s answer to its worker shortage: An AI model for 10 million robots

Japan’s AI robots plan just went from a talking point to a formal national strategy. This week, the government confirmed the numbers everyone’s been quoting: 10 million AI-powered robots deployed across 18 industries by 2040, backed by public funding of up to one trillion yen, or roughly US$6.1 billion, over five years. The headline figure […]

The post Japan’s answer to its worker shortage: An AI model for 10 million robots appeared first on AI News.

Read more




--- 您可能还感兴趣 ---
想要了解更多资讯,请点击查看澳纽网最新文章列表:
👉 [点击此处查看全部最新文章]
------------------------------------
请小编喝咖啡☕️
------------------------------------




广告 | Advertisement

在澳纽网做广告 | Advertise with us